Acute Musculoskeletal Pain Management

Introduction to Guidelines

The Centers for Disease Control and Prevention (CDC) recommends using methocarbamol as a short-term adjunct therapy with hydrocodone prescribed at the lowest effective dose for no more than 7 days, with careful monitoring for respiratory depression and sedation, for patients with acute musculoskeletal pain 1
The American College of Physicians (ACP) and American Academy of Family Physicians (AAFP) recommend against using opioids, including tramadol, for acute musculoskeletal pain, reserving them for severe and debilitating pain not controlled with acetaminophen and NSAIDs 2, 3

The American Geriatrics Society recommends that for elderly patients, lower starting doses of methocarbamol may be required, with an increased risk of adverse effects, particularly sedation and falls, and monitoring more frequently for side effects 4
Patients with sleep apnea, renal or hepatic insufficiency, or those taking concurrent CNS depressants are at higher risk for respiratory depression, especially within the first 24-72 hours of initiating therapy 1
The CDC recommends checking the prescription drug monitoring program before prescribing hydrocodone, assessing the patient's risk for opioid misuse, abuse, or diversion, and considering offering naloxone if the patient has risk factors for overdose 1, 5

Hydrocodone should be prescribed at a dose of 5 mg every 4-6 hours as needed, with a maximum daily dosage of no more than 6-8 tablets per day, and for a duration of 7 days or less to prevent dependence 1, 5
Methocarbamol dosing should be limited to short-term use only, typically 1-2 weeks, with a maximum duration of 6 grams daily recommended for the first 48-72 hours, then reduced to 4 grams daily 4
Oral NSAIDs can be used if greater pain relief is required, but cardiovascular and gastrointestinal risk factors should be evaluated before prescribing, and the lowest effective dose should be used for the shortest necessary period 3

Topical NSAIDs with or without menthol gel are recommended as first-line therapy for acute musculoskeletal pain due to their efficacy in pain reduction, improvement in physical function, and favorable safety profile, providing significant pain reduction within 2 hours (WMD, −1.02 cm on a 10-cm pain scale) and continuing to provide pain relief at 1-7 days (WMD, −1.08 cm) 2
Massage therapy can reduce pain within 2 hours (WMD, −0.70 cm to −1.94 cm) and continues to provide pain relief at 1-7 days (WMD, −1.07 cm to −1.18 cm), improving physical function (WMD, 1.51 cm) 2
Acupressure and Transcutaneous Electrical Nerve Stimulation (TENS) can also be used to reduce pain and improve physical function 2

Patients should be advised against driving or operating machinery due to combined sedative effects, and concurrent use of benzodiazepines or other sedating medications should be avoided 1
NSAIDs carry significant risks, including cardiovascular risks such as increased risk of myocardial infarction, and renal risks such as adverse renovascular effects, and should be used judiciously 3
Opioids, including tramadol, should be avoided for the treatment of acute non-lumbar musculoskeletal pain, and should only be considered when pain is severe and debilitating, and not controlled with acetaminophen and NSAIDs, and should be used for short periods 2, 3

For patients with risk factors for overdose, the CDC recommends considering offering naloxone, and for patients taking opioids around the clock for more than a few days, a tapering plan should be included 1
Extended-release opioid formulations should never be used for acute pain, and scheduled dosing of hydrocodone should be avoided, instead prescribing as needed 1, 5
Tricyclic antidepressants can be used for chronic lumbar pain, and gabapentin can be used for patients with radiculopathy 3